The non-selective pan-histone deacetylase inhibitor Panobinostat [97] and the global histone methylation inhibitor 3-deazanoplanocin A (DzNep) [98] act synergistically to deplete EZH2 and induce apoptosis in primary MCL cells in vitro [99]. This evidence concerns the gene EZH2 and mantle cell lymphoma.